Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Expression of the miR-17-92 cluster and paralogues in triple-negative tumors compared to others, using microarray

From: Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study

MiRNA Triple-negative tumors Not triple-negative tumors logFC p*
Mean SD Mean SD
miR-17-5p 6.80 1.10 6.22 0.50 0.581 0.0029
miR-20a-5p 7.16 1.05 6.60 0.42 0.566 0.0021
miR-92a-3p 7.55 0.75 7.17 0.44 0.384 0.011
miR-106b-5p 6.84 0.72 6.50 0.45 0.341 0.021
miR-93-5p 7.23 0.76 6.96 0.51 0.270 0.094
miR-25-3p 6.66 0.41 6.51 0.31 0.147 0.10
  1. Expression levels are given as the mean (standard deviation) of log2 transformed intensity values (Hy3) by microarray analyses
  2. * False discovery rate (FDR) adjusted p-value